Of note, these metabolic changes, indicated by GLUT1 and p-AMPK expression, were maintained in similarly sized tumors, thus supporting effects that may be due to increases in tumor bulk by GPx2 KD (SI Appendix, Fig. S4G). This evidence concerns the gene SLC2A1 and neoplasm.